Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Legislative Session number- 84

Bill Name: SF3342

2E "Patient Safety and Drug Review Transparency Act"; requiring disclosure of
clinical trials for prescription drugs by manufacturers; specifying certain
information disclosure and application requirements; requiring posting of
clinical trail information on an accessible internet web site; defining certain
terms; assessing fees; specifying certain compliance dates
(me)